Cargando…
Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
OBJECTIVE: To describe treatment regimens in youth with type 2 diabetes and examine associations between regimens, demographic and clinical characteristics, and glycemic control. RESEARCH DESIGN AND METHODS: This report includes 474 youth with a clinical diagnosis of type 2 diabetes who completed a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867996/ https://www.ncbi.nlm.nih.gov/pubmed/24026554 http://dx.doi.org/10.2337/dc13-1124 |
_version_ | 1782296392434188288 |
---|---|
author | Badaru, Angela Klingensmith, Georgeanna J. Dabelea, Dana Mayer-Davis, Elizabeth J. Dolan, Lawrence Lawrence, Jean M. Marcovina, Santica Beavers, Daniel Rodriguez, Beatriz L. Imperatore, Giuseppina Pihoker, Catherine |
author_facet | Badaru, Angela Klingensmith, Georgeanna J. Dabelea, Dana Mayer-Davis, Elizabeth J. Dolan, Lawrence Lawrence, Jean M. Marcovina, Santica Beavers, Daniel Rodriguez, Beatriz L. Imperatore, Giuseppina Pihoker, Catherine |
author_sort | Badaru, Angela |
collection | PubMed |
description | OBJECTIVE: To describe treatment regimens in youth with type 2 diabetes and examine associations between regimens, demographic and clinical characteristics, and glycemic control. RESEARCH DESIGN AND METHODS: This report includes 474 youth with a clinical diagnosis of type 2 diabetes who completed a SEARCH for Diabetes in Youth study visit. Diabetes treatment regimen was categorized as lifestyle alone, metformin monotherapy, any oral hypoglycemic agent (OHA) other than metformin or two or more OHAs, insulin monotherapy, and insulin plus any OHA(s). Association of treatment with demographic and clinical characteristics (fasting C-peptide [FCP], diabetes duration, and self-monitoring of blood glucose [SMBG]), and A1C was assessed by χ(2) and ANOVA. Multiple linear regression models were used to evaluate independent associations of treatment regimens and A1C, adjusting for demographics, diabetes duration, FCP, and SMBG. RESULTS: Over 50% of participants reported treatment with metformin alone or lifestyle. Of the autoantibody-negative youth, 40% were on metformin alone, while 33% were on insulin-containing regimens. Participants on metformin alone had a lower A1C (7.0 ± 2.0%, 53 ± 22 mmol/mol) than those on insulin alone (9.2 ± 2.7%, 77 ± 30 mmol/mol) or insulin plus OHA (8.6 ± 2.6%, 70 ± 28 mmol/mol) (P < 0.001). These differences remained significant after adjustment (7.5 ± 0.3%, 58 ± 3 mmol/mol; 9.1 ± 0.4%, 76 ± 4 mmol/mol; and 8.6 ± 0.4%, 70 ± 4 mmol/mol) (P < 0.001) and were more striking in those with diabetes for ≥2 years (7.9 ± 2.8, 9.9 ± 2.8, and 9.8 ± 2.6%). Over one-half of those on insulin-containing therapies still experience treatment failure (A1C ≥8%, 64 mmol/mol). CONCLUSIONS: Approximately half of youth with type 2 diabetes were managed with lifestyle or metformin alone and had better glycemic control than individuals using other therapies. Those with longer diabetes duration in particular commonly experienced treatment failures, and more effective management strategies are needed. |
format | Online Article Text |
id | pubmed-3867996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-38679962015-01-01 Correlates of Treatment Patterns Among Youth With Type 2 Diabetes Badaru, Angela Klingensmith, Georgeanna J. Dabelea, Dana Mayer-Davis, Elizabeth J. Dolan, Lawrence Lawrence, Jean M. Marcovina, Santica Beavers, Daniel Rodriguez, Beatriz L. Imperatore, Giuseppina Pihoker, Catherine Diabetes Care Clinical Care/Education/Nutrition/Psychosocial Research OBJECTIVE: To describe treatment regimens in youth with type 2 diabetes and examine associations between regimens, demographic and clinical characteristics, and glycemic control. RESEARCH DESIGN AND METHODS: This report includes 474 youth with a clinical diagnosis of type 2 diabetes who completed a SEARCH for Diabetes in Youth study visit. Diabetes treatment regimen was categorized as lifestyle alone, metformin monotherapy, any oral hypoglycemic agent (OHA) other than metformin or two or more OHAs, insulin monotherapy, and insulin plus any OHA(s). Association of treatment with demographic and clinical characteristics (fasting C-peptide [FCP], diabetes duration, and self-monitoring of blood glucose [SMBG]), and A1C was assessed by χ(2) and ANOVA. Multiple linear regression models were used to evaluate independent associations of treatment regimens and A1C, adjusting for demographics, diabetes duration, FCP, and SMBG. RESULTS: Over 50% of participants reported treatment with metformin alone or lifestyle. Of the autoantibody-negative youth, 40% were on metformin alone, while 33% were on insulin-containing regimens. Participants on metformin alone had a lower A1C (7.0 ± 2.0%, 53 ± 22 mmol/mol) than those on insulin alone (9.2 ± 2.7%, 77 ± 30 mmol/mol) or insulin plus OHA (8.6 ± 2.6%, 70 ± 28 mmol/mol) (P < 0.001). These differences remained significant after adjustment (7.5 ± 0.3%, 58 ± 3 mmol/mol; 9.1 ± 0.4%, 76 ± 4 mmol/mol; and 8.6 ± 0.4%, 70 ± 4 mmol/mol) (P < 0.001) and were more striking in those with diabetes for ≥2 years (7.9 ± 2.8, 9.9 ± 2.8, and 9.8 ± 2.6%). Over one-half of those on insulin-containing therapies still experience treatment failure (A1C ≥8%, 64 mmol/mol). CONCLUSIONS: Approximately half of youth with type 2 diabetes were managed with lifestyle or metformin alone and had better glycemic control than individuals using other therapies. Those with longer diabetes duration in particular commonly experienced treatment failures, and more effective management strategies are needed. American Diabetes Association 2014-01 2013-12-11 /pmc/articles/PMC3867996/ /pubmed/24026554 http://dx.doi.org/10.2337/dc13-1124 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Clinical Care/Education/Nutrition/Psychosocial Research Badaru, Angela Klingensmith, Georgeanna J. Dabelea, Dana Mayer-Davis, Elizabeth J. Dolan, Lawrence Lawrence, Jean M. Marcovina, Santica Beavers, Daniel Rodriguez, Beatriz L. Imperatore, Giuseppina Pihoker, Catherine Correlates of Treatment Patterns Among Youth With Type 2 Diabetes |
title | Correlates of Treatment Patterns Among Youth With Type 2 Diabetes |
title_full | Correlates of Treatment Patterns Among Youth With Type 2 Diabetes |
title_fullStr | Correlates of Treatment Patterns Among Youth With Type 2 Diabetes |
title_full_unstemmed | Correlates of Treatment Patterns Among Youth With Type 2 Diabetes |
title_short | Correlates of Treatment Patterns Among Youth With Type 2 Diabetes |
title_sort | correlates of treatment patterns among youth with type 2 diabetes |
topic | Clinical Care/Education/Nutrition/Psychosocial Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867996/ https://www.ncbi.nlm.nih.gov/pubmed/24026554 http://dx.doi.org/10.2337/dc13-1124 |
work_keys_str_mv | AT badaruangela correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT klingensmithgeorgeannaj correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT dabeleadana correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT mayerdaviselizabethj correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT dolanlawrence correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT lawrencejeanm correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT marcovinasantica correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT beaversdaniel correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT rodriguezbeatrizl correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT imperatoregiuseppina correlatesoftreatmentpatternsamongyouthwithtype2diabetes AT pihokercatherine correlatesoftreatmentpatternsamongyouthwithtype2diabetes |